Coronary heart disease associated with the use of human immunodeficiency virus (HIV)-1 protease inhibitors: Report of four cases and review

Clinical Cardiology

Volumn 24, Issue 10, 2001, Pages 690-694

  Duong, M ^a   Buisson, M ^a   Cottin, Y ^a   Piroth, L ^a   Lhuillier, I ^a   Grappin, M ^a   Chavanet, P ^a   Wolff, J E ^a   Portier, H ^a  

^a HÔPITAL DU BOCAGE   (France)

Author keywords

Acquired immune deficiency syndrome; Coronary heart disease; Dyslipidemia; HIV 1 protease inhibitor; Human immunodeficiency virus (HIV) infection; Myocardial infarction

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLYCERYL TRINITRATE; INDINAVIR; LAMIVUDINE; NELFINAVIR; NEVIRAPINE; PROTEINASE INHIBITOR; RITONAVIR; SAQUINAVIR; STAVUDINE; ZALCITABINE; ZIDOVUDINE;

ADULT; ARTICLE; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CLINICAL FEATURE; CORONARY ARTERY DISEASE; DYSLIPIDEMIA; HEART INFARCTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERCHOLESTEROLEMIA; MALE; RISK FACTOR;

EID: 0034804512     PISSN: 01609289     EISSN: None     Source Type: Journal    
DOI: 10.1002/clc.4960241011     Document Type: Article

References (31)

1. Protease inhibitors for the treatment of human immunodeficiency virus infection
2. HIV protease inhibitors: Advances in therapy and adverse reactions including metabolic complications
3. Vascular complications associated with the use of HIV protease inhibitors
4. Is treatment with ritonavir a risk factor for myocardial infarction in HIV-infected patients?
5. Vascular complications associated with the use of HIV protease inhibitors
6. Severe premature coronary artery disease with protease inhibitors
7. Increased morbidity from myocardial infarction during HIV protease inhibitor treatment
8. Severe coronary artery disease in a young HIV-infected man with no cardiovascular risk factor who was treated with indinavir
9. Infarctus du myocarde sous antiproteases
10. Vascular complications associated with the use of HIV protease inhibitors
11. Cardiac manifestations of HIV/AIDS
12. Conduction syndrome in children with AIDS
13. Coronary artery bypass in patients with HIV
14. Arteriopathy in children with acquired immune deficiency syndrome
15. Coronary artery lesions and HIV infection
16. Plasma lipids in HIV-infected patients: A prospective study in 95 patients
17. Asymptomatic atherosclerosis in HIV-positive patients: A case-control ultrasound study
18. Protease inhibitor-associated hyperglycaemia
19. Lipoprotein alterations in patients with HIV infection: Relation with cellular and humoral immune markers
20. High triglyceride levels as a predictor of mortality in AIDS patients
21. Circulating interferon-alpha levels and hypertriglyceridemia in the acquired immunodeficiency syndrome
22. The impact of HIV progression on serum lipoproteins
23. Decreased plasma concentrations of HDL cholesterol in HIV-infected individuals are associated with immune activation
24. Cardiomyopathy associated with antiretroviral therapy in patients with HIV infection: A report of six cases
25. Abnormal fat accumulation in patients with HIV-1 infection
26. A syndrome of peripheral lipodystrophy, hyperlipidemia and insuline resistance in patients receiving HIV protease inhibitors
27. Pathogenesis of HIV-1-protease inhibitor-associated peripheral lipodystrophy, hyperlipidaemia, and insuline resistance
28. Metabolic abnormalities and body fat redistribution in HIV-1 infected patients: The lipodystrophy syndrome
29. Treatment with protease inhibitors associated with peripheral insulin resistance and impaired oral glucose tolerance in HIV-1 infected patients
30. An updated coronary risk profile: Statement for health professionals
31. Triglyceride concentration and ischemic heart disease: An eight-year follow-up in the Copenhagen Male Study